Hyderabad: Telangana govt, King's College London tie-up for Pharma university

The partnership fostered between King's college and Telangana will help support the vision of Pharma City, of which the creation of a life sciences higher education provision forms a key element - drawing together innovation, research and development and excellence.

Published On 2022-05-20 09:03 GMT   |   Update On 2022-05-20 09:03 GMT

New Delhi: The Telangana government on Thursday signed a Memorandum of Understanding (MoU) with King's College London in connection with the proposed Pharma University at Hyderabad Pharma City.

The MoU was signed in the presence of state Minister for IT and Industries KT Rama Rao, who is currently camping in the UK, an official release said.  

Read also: Telangana Minister K T Rama Rao inaugrates Ferring Pharma Genome Valley facility

The MoU sets out a joint intention between King's College and the Telangana government to explore the development of higher educational provision within the Pharma City and will involve collaborative research projects, staff and student exchanges, as well as curriculum development and upskilling.

The partnership fostered between King's college and Telangana will help support the vision of Pharma City, of which the creation of a life sciences higher education provision forms a key element - drawing together innovation, research and development and excellence.

Read also: Hyderabad: KT Rama Rao inaugurates Sahajanand Medical Technologies stent manufacturing facility

At the signing ceremony, Rama Rao said, " Spread across 19,000 acres, Hyderabad Pharma City will be the world's largest pharma cluster and the establishment of a Life Sciences & Pharma University is an integral part of the Pharma City vision. With Telangana's life sciences ecosystem estimated at USD 50 bn, combined with King's College London's world leading expertise in research and training, I'm hopeful that this collaboration will deliver mutually beneficial partnerships for both Telangana and the UK."

Prof. Shitij Kapur, President and Principal of King's College London said, "This collaboration represents an exciting opportunity to develop higher education provision in Telangana with a focus on areas with current global significance and in which King's has world leading expertise, including technology and health care."

Read also: Boehringer Ingelheim's empagliflozin gets CDSCO nod for heart failure with preserved ejection fraction

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News